SEC Form 4 · accession 0001061983-17-000042
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert I Blum
Officer — President & CEO · Director
Period of report
Jul 3, 2017
Accepted (ET)
Jul 5, 2017 · 9:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 3, 2017 | S | 1,500 | $12.10 | D | 88,385 | D | |
| Common Stock | Jul 3, 2017 | S | 3,091 | $12.15 | D | 85,294 | D | |
| Common Stock | Jul 3, 2017 | S | 100 | $12.175 | D | 85,194 | D | |
| Common Stock | Jul 3, 2017 | S | 309 | $12.20 | D | 84,885 | D | |
| Common StockF2 | holding | — | — | — | 2,083 | I | by Trust 1 | |
| Common StockF3 | holding | — | — | — | 2,083 | I | by Trust 2 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017.
- F2Shares held by The Bridget Blum 2003 Irrevocable Trust.
- F3Shares held by The Brittany Blum 2003 Irrevocable Trust.